Drugs / magnesium aluminum oxide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01262560 Comparator | Feb 2012 → Feb 2014 | esophagitis, lung neoplasm | Radiation Therapy Oncology Group | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | magnesium aluminum oxide | “A compound containing viscous lidocaine and magnesium aluminum oxide (Maalox®);” NCT01262560 ↗ |